Cerebrovasular imaging company iSchemaView has received the FDA nod for its latest product the RAPID CTA, a 3D imaging platform for computed tomogrpahy angiography (CTA). “Our goal is to provide ... Business Wire: RapidAI Secures FDA 510(k) Clearance for Groundbreaking AI 3D Head and Neck CTA Imaging: Lumina 3D™ RapidAI Secures FDA 510(k) Clearance for Groundbreaking AI 3D Head and Neck CTA Imaging: Lumina 3D™ SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in AI-driven medical imaging analysis and coordinated care, has received FDA 510(k) clearance for Lumina 3D™ by RapidAI—an industry-first ...
The author proposes Ves-GAN, a novel unsupervised vessel-targeted denoising framework based on the architecture of Cycle-GAN. Ves-GAN achieves global denoising of LDCTA images while selectively ... CTAHN leads to acute management changes in a minority of patients, with the highest diagnostic yield found in stroke and headache cases. The New England Journal of Medicine: Intravascular Imaging–Guided or Angiography-Guided Complex PCI Data regarding clinical outcomes after intravascular imaging–guided percutaneous coronary intervention (PCI) for complex coronary-artery lesions, as compared with outcomes after angiography-guided PCI ...
